United States · 
Who invested in Glyphic Biotechnologies?
Glyphic Biotechnologies's investors include Gaingels, Wing Venture Capital, Artis Ventures (AV) and Cantos.
United States · Series A startup
Who invested in Glyphic Biotechnologies
Funding summaryUpdated 26 Oct 2026
$38Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $38MSept 2025
- Investors
- 4
The rounds
- Sept 2025
Founders and team
From the SEC filings it signed: 2 on the team.
- Daniel EstandianExecutive Officer, Directori
- Joshua YangExecutive Officer, Directori
On the board, as filediCraig AsherJimmy Yun
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Glyphic Biotechnologies as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Glyphic Biotechnologies
How much has Glyphic Biotechnologies raised?
Glyphic Biotechnologies has raised $38M across 1 round since 2025.
When did Glyphic Biotechnologies last raise?
Glyphic Biotechnologies's most recent round was a Series A of $38M in Sept 2025.
What was Glyphic Biotechnologies's biggest round?
Its most recent round, $38M in Sept 2025, is also its largest on record.
Who backed Glyphic Biotechnologies first?
Glyphic Biotechnologies's first round on record, in Sept 2025, was backed by Gaingels, Wing Venture Capital and Artis Ventures (AV) and 1 others.
What stage is Glyphic Biotechnologies at?
Glyphic Biotechnologies's latest named round is a Series A, in Sept 2025.
Where is Glyphic Biotechnologies based?
Glyphic Biotechnologies is based in the United States.
Companies like Glyphic Biotechnologies
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.